Suppr超能文献

胆汁中的幽门螺杆菌DNA:与肝胆疾病的相关性。

Helicobacter DNA in bile: correlation with hepato-biliary diseases.

作者信息

Fallone C A, Tran S, Semret M, Discepola F, Behr M, Barkun A N

机构信息

Department of Medicine, McGill University Health Centre, McGill University, West Montreal, Quebec, Canada.

出版信息

Aliment Pharmacol Ther. 2003 Feb;17(3):453-8. doi: 10.1046/j.1365-2036.2003.01424.x.

Abstract

BACKGROUND

Helicobacter has been identified in isolated cases of hepato-biliary diseases, but its role in the pathogenesis of these conditions remains unclear.

AIM

To determine whether Helicobacter could be detected in bile obtained at endoscopic retrograde cholangiopancreatography, and to evaluate the prevalence of this infection in patients with hepato-biliary diseases.

METHODS

Bile was collected from 125 patients with various hepato-biliary diseases undergoing endoscopic retrograde cholangiopancreatography. Among them, 75 were diagnosed with biliary stones, 15 with pancreatico-biliary malignancies and four with primary sclerosing cholangitis. The detection of Helicobacter in DNA extracted from these bile samples was performed using Helicobacter genus-specific primers (capable of detecting 100-1000 organisms/mL).

RESULTS

Helicobacter was detected in all positive controls. Only three samples had polymerase chain reaction inhibitors. All remaining bile samples (122 patients with hepato-biliary diseases) were negative for Helicobacter DNA.

CONCLUSIONS

Helicobacter can be detected in bile samples using polymerase chain reaction. This infection, however, was not present in any of our patients diagnosed with gallstones or hepato-biliary malignancies, raising doubt as to the possible association between Helicobacter and these entities. Given the low sample size of patients with primary sclerosing cholangitis, more studies are required to determine whether an association exists with this condition.

摘要

背景

在个别肝胆疾病病例中已发现幽门螺杆菌,但它在这些疾病发病机制中的作用仍不清楚。

目的

确定在经内镜逆行胰胆管造影术获取的胆汁中是否能检测到幽门螺杆菌,并评估这种感染在肝胆疾病患者中的患病率。

方法

从125例接受经内镜逆行胰胆管造影术的各种肝胆疾病患者中收集胆汁。其中,75例被诊断为胆结石,15例为胰胆管恶性肿瘤,4例为原发性硬化性胆管炎。使用幽门螺杆菌属特异性引物(能够检测100 - 1000个菌/毫升)对从这些胆汁样本中提取的DNA进行幽门螺杆菌检测。

结果

在所有阳性对照中均检测到幽门螺杆菌。只有3个样本含有聚合酶链反应抑制剂。其余所有胆汁样本(122例肝胆疾病患者)的幽门螺杆菌DNA检测均为阴性。

结论

使用聚合酶链反应可在胆汁样本中检测到幽门螺杆菌。然而,在我们诊断为胆结石或肝胆恶性肿瘤的任何患者中均未发现这种感染,这对幽门螺杆菌与这些疾病之间可能存在的关联提出了质疑。鉴于原发性硬化性胆管炎患者的样本量较小,需要更多研究来确定是否与这种疾病存在关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验